Clinical trials are expensive, take significant time, and can run into any number of challenges and delays. The average drug study will see a 30%
Source: PubsOnline Over the past two years, the testing of new medical devices, drugs and vaccines has increasingly been performed outside large medical centers. Faster
Source: ACRP There’s more to the quest of fostering diversity, equity, and inclusion in the delivery of clinical research opportunities than just reaching race/ethnicity-, gender-,
Maximizing Clinical Trial Access, Diversity, and Efficiency are Keys to Optimizing Orphan Drug Development February 22, 2022 February is Rare Disease Month—an important time when
Source: Insightcare By Harsha Rajasimha, PhD, Founder and CEO, Jeeva Clinical Trials Inc. www.jeevatrials.com To say that COVID-19 has been a challenge to healthcare systems
The COVID-19 pandemic brought a new sense of appreciation for clinical trials as masses watched clinical trials closely while pharmaceutical companies raced against the clock
Source: MarketScale Clinical trials can save lives and provide new ways to treat disease. The industry estimates that 85% of all clinical trials face delays
The loss of his daughter to a rare congenital disorder in the United States and the passing of his younger brother in India from complications
The growing use of decentralized clinical trials has raised serious concerns regarding verification of patient comprehension and proper informed consent. The solution, says Dr. Harsha
Source: Healthcare Weekly Almost everything went online due to the COVID-19 pandemic, from remote collaboration with coworkers to ordering groceries and conducting online classes. But
Jeeva Clinical Trials Inc.
